B

Bavarian Nordic A/S
CSE:BAVA

Watchlist Manager
Bavarian Nordic A/S
CSE:BAVA
Watchlist
Price: 204.8 DKK 2.35% Market Closed
Market Cap: 16.1B DKK
Have any thoughts about
Bavarian Nordic A/S?
Write Note

Bavarian Nordic A/S
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bavarian Nordic A/S
Other Equity Peer Comparison

Comparables:
GMAB
ZEAL
ASND
F
FLUO
BIOPOR

Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
B
Bavarian Nordic A/S
CSE:BAVA
Other Equity
-kr16.5m
CAGR 3-Years
23%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Other Equity
kr234m
CAGR 3-Years
42%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Zealand Pharma A/S
CSE:ZEAL
Other Equity
kr22.7m
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ascendis Pharma A/S
NASDAQ:ASND
Other Equity
-€329m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
F
Fluoguide AS
STO:FLUO
Other Equity
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Other Equity
-kr84k
CAGR 3-Years
N/A
CAGR 5-Years
23%
CAGR 10-Years
N/A

See Also

What is Bavarian Nordic A/S's Other Equity?
Other Equity
-16.5m DKK

Based on the financial report for Jun 30, 2024, Bavarian Nordic A/S's Other Equity amounts to -16.5m DKK.

What is Bavarian Nordic A/S's Other Equity growth rate?
Other Equity CAGR 5Y
15%

Over the last year, the Other Equity growth was 39%. The average annual Other Equity growth rates for Bavarian Nordic A/S have been 23% over the past three years , 15% over the past five years .

Back to Top